BCL6 and familial pancreatic carcinoma: As demonstrated in pancreatic cancer cells upon binding of GW501516, PPARβ/δ decreased TNFα (Tumor Necrosis Factor α)-induced NFκB activity leading to the induction of anti-inflammatory genes and consequently to the inhibition of pro-inflammatory genes through the dissociation of BCL6 [42].